Cannabinoids may provide a potential therapeutic target for sexual dysfunctions, according to a study published in the journal Pharmacological Research. The study was published online by the U.S. National Institute of Health.
“The endocannabinoid system (ECS), which is composed of the cannabinoid receptors types 1 and 2 (CB1 and CB2) for marijuana’s psychoactive ingredient Δ9-tetrahydrocannabinol (Δ9-THC)… recently emerged as important modulator of emotional and non-emotional behavior”, begins the study’s abstract. “For centuries, in addition to its recreational actions, several contradictory claims regarding the effects of Cannabis use in sexual functioning and behavior (e.g. aphrodisiac vs anti-aphrodisiac) of both sexes have been accumulated.”